市場調査レポート
商品コード
1362409

バイオ分析検査サービス市場規模および予測、世界および地域シェア、動向、成長機会分析レポート対象範囲:サービス別、適応疾患別、エンドユーザー別、地域別

Bioanalytical Testing Services Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services ; Disease Indication ; End User, and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 202 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
バイオ分析検査サービス市場規模および予測、世界および地域シェア、動向、成長機会分析レポート対象範囲:サービス別、適応疾患別、エンドユーザー別、地域別
出版日: 2023年09月14日
発行: The Insight Partners
ページ情報: 英文 202 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオ分析検査サービスの世界市場は、2022年の46億4,113万米ドルから2030年には101億882万米ドルに達すると予測されます。2022年から2030年までのCAGRは10.2%で成長すると推定されます。

市場の成長を促す主な要因は、製薬企業による研究開発活動のアウトソーシングの増加、バイオシミラーや生物製剤の分析試験に対する需要の高さです。しかし、バイオ分析法の開発と検証における課題が、市場の成長をある程度妨げています。

バイオ分析試験サービス市場の市場機会

医薬品やその他の医薬品の研究開発、生産、流通は製薬産業の主要分野です。世界の医薬品消費量は、加齢関連疾患や慢性疾患の治療薬に対するニーズの高まりとともに増加しています。WHOによると、60歳以上の高齢者人口は2020年から2050年にかけて倍増し、2050年には21億人に達すると予測されています。高齢者人口の増加は、心血管疾患、がん、高血圧、変形性関節症、糖尿病などの慢性疾患の発生を急増させる。そのため、慢性疾患は製薬会社の主要な注力分野となっています。

新薬開発は、資源、コスト、時間の集約的なプロセスであり、後期臨床段階では多大なコストがかかります。米国議会予算局(CBO)によれば、医薬品を発見し、規制当局の承認を得るまでには10~15年以上かかり、およそ1~20億米ドルの費用がかかります。そのため、医薬品研究開発における消耗率を下げるため、製薬会社は米国FDAやその他の主要規制機関が定めた適正製造規範(GMP)に従うことに注力しています。いくつかの製薬会社は、臨床段階と前臨床段階の両方で、医薬品開発とアッセイのバリデーションのためにバイオ分析試験サービスを選択しています。ジェネリック医薬品と先発医薬品は、ほとんどが低分子化合物です。ジェネリック医薬品メーカーは、特許失効の問題を克服するためにバイオ分析試験結果を実施し、提出します。このように、製薬業界の絶え間ない増殖に伴い、バイオ分析試験サービス・プロバイダーは、将来そのサービスに対する需要が継続的に増加する可能性が高く、バイオ分析試験サービス市場の新たな成長機会につながると思われます。

バイオ分析試験サービス市場を阻害する要因

バイオ分析法の開発は複雑なプロセスであり、熟練した専門家による器用なアプローチが必要です。その結果、生物学的分析法の開発とバリデーションにはいくつかの課題が伴う。複雑な臨床試験を行う英国の臨床研究機関Simbec-Orionによると、FDAの審査官は、生物学的分析試験法に関する分析上の問題、抽出技術の欠陥、計算上の問題、報告上の問題、サンプル出荷の問題などの課題について概説しています。サンプル調製と分析の段階で様々な分析上の問題が生じる可能性があります。これらには、HPLCにおける分析カラムの劣化、移動相の汚染、LCMSにおけるサンプルマトリックスの複雑さから生じる問題、LCMSの他の段階の汚染などが含まれます。これらはバイオ分析試験のバリデーションを妨げ、同時に品質基準にも影響を与えるため、バイオ分析試験サービス市場の成長を制限しています。

バイオ分析試験サービス市場セグメント別概要

バイオ分析試験サービス市場は、サービスに基づき、薬物動態学、バイオマーカー、免疫原性、ウイルス学試験、細胞ベースアッセイ、その他に区分されます。2022年には、セルベースアッセイセグメントが最大の市場シェアを占めています。さらに、同セグメントは2022年から2030年にかけて最も高いCAGRを記録すると予測されています。細胞ベースアッセイは、医薬品や原薬の生物学的活性(力価)を測定し、作用機序(MOA)を発見するため、また細胞毒性試験や初期段階の原理実証試験に一般的に使用されます。一方、免疫原性試験では、患者の体内で産生される抗体の薬物中和効果を判定するのに役立ちます。

生物学的分析試験サービス市場は、適応疾患に基づいて、心血管、神経障害(CNS)、代謝障害、腫瘍学、性の健康、骨疾患、その他に区分されます。2022年には、腫瘍学セグメントが市場最大のシェアを占めました。また、疼痛緩和、化学療法、その他の治療における腫瘍学の進歩により、同分野は2022年から2030年にかけて最も速いCAGRで需要が伸びると予測されています。

バイオ分析試験サービス市場は、エンドユーザーに基づき、製薬・バイオ医薬品企業、受託研究機関(CRO)、受託開発・製造機関(CDMO)、その他に区分されます。2022年には、製薬・バイオ医薬品企業が最大の市場シェアを占めています。さらに、同セグメントは2022年から2030年にかけて最も速いCAGRで需要が伸びると予想されています。バイオ分析試験サービスは、医薬品製造の開始から最終製品リリースまでに関わるリスクを排除することを目的としています。したがって、創薬および市場開拓におけるバイオ分析試験サービスの重要性は、製薬会社およびバイオ製薬会社セグメントのバイオ分析試験サービス市場を牽引しています。

バイオ分析試験サービス市場地域別概要

世界のバイオ分析試験サービス市場では、北米が最大のシェアを占めており、アジア太平洋地域は急成長している地域です。北米の市場は、製薬産業の絶え間ない成長、さまざまな疾病の急増による新薬開発のニーズの高まり、政府によるヘルスケア支出の増加、医薬品の品質保証のためのアウトソーシング活動への嗜好の高まりにより、予測期間中に成長すると予想されます。アジア太平洋地域は、世界の生物学的分析試験サービス市場で最も高いCAGRを記録しました。同地域の市場は、中国、インド、日本を含む国々で今後数年間に大きく成長すると予想されます。アジア太平洋市場は、低コストの労働市場においてアウトソーシングサービスの需要が高まっていることから、成長が見込まれています。したがって、この地域は予測期間中にバイオ分析検査サービス市場プレーヤーが成長する大きな可能性を秘めています。

バイオ分析検査サービス市場に関するレポート作成時に参照した主な一次情報および二次情報は、World Bank Data、National Health Service(NHS)、FDA(Food and Drug Administration)、EMA(European Medicines Agency)、EPA(Environmental Protection Agency)などです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 バイオ分析検査サービス市場情勢

  • PEST分析
    • 北米PEST分析
    • 欧州PEST分析
    • アジア太平洋PEST分析
    • 中南米PEST分析
    • 中東・アフリカPEST分析

第5章 バイオ分析検査サービス市場:主要産業力学

  • 主な市場促進要因
    • 製薬企業による研究開発活動のアウトソーシングの増加
    • バイオシミラーおよび生物製剤の分析試験に対する高い需要
  • 主な市場抑制要因
    • バイオ分析法の開発とバリデーションにおける課題
  • 主な市場機会
    • 医薬品産業の絶え間ない成長
  • 今後の動向
    • 新興・希少疾患に対する創薬・開発活動の活発化
  • インパクト分析

第6章 バイオ分析検査サービス市場:世界市場分析

  • バイオ分析検査サービス市場の収益、2022年~2030年

第7章 バイオ分析検査サービス市場バイオ分析検査サービスの世界市場-2030年までの収益と予測- サービス別

  • バイオ分析検査サービス市場収益シェア、サービス別、2022年・2030年(%)
  • 薬物動態学
  • バイオマーカー
  • 免疫原性
  • ウイルス検査
  • 細胞ベースアッセイ
  • その他

第8章 バイオ分析検査サービスの世界市場:2030年までの収益と予測:適応疾患別

  • バイオ分析検査サービス市場:2022年および2030年疾患適応症別売上高シェア(%)
  • 心血管疾患
  • 神経疾患
  • 自己免疫疾患
  • 呼吸器疾患
  • 代謝疾患
  • 腫瘍学
  • 性の健康
  • 骨疾患
  • その他

第9章 バイオ分析検査サービスの世界市場:エンドユーザー別収益と2030年までの予測

  • バイオ分析検査サービス市場エンドユーザー別2022年・2030年売上高シェア(%)
  • 製薬会社およびバイオ医薬品会社
  • 開発業務受託機関(CRO)
  • 開発製造受託機関(CDMO)
  • その他

第10章 バイオ分析検査サービス市場- 地域分析

  • 北米
    • メキシコ
  • 欧州
    • その他欧州
  • アジア太平洋
    • その他アジア太平洋地域
  • 中東・アフリカ
    • その他中東とアフリカ
  • 中南米
    • その他中南米

第11章 COVID-19前後の影響

  • COVID-19前後の影響

第12章 バイオ分析検査サービス市場の業界情勢

  • バイオ分析検査サービス市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第13章 企業プロファイル

  • SGS SA
  • Pharmaron Beijing Co Ltd
  • Element Materials Technology Group Ltd
  • CD BioSciences Inc
  • Charles River Laboratories International Inc
  • Eurofins Scientific SE
  • Labcorp Drug Development Inc
  • Syneos Health Inc
  • KCAS Bioanalytical and Biomarker Services LLC
  • ICON Plc
  • Intertek Group Plc

第14章 付録

図表

List Of Tables

  • Table 1. Bioanalytical Testing Services Market Segmentation
  • Table 2. North America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 3. North America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 4. North America Bioanalytical Testing Services Market Revenue And Forecast To 2030 (US$ Mn) - Disease Indication
  • Table 5. North America Bioanalytical Testing Services Market Revenue And Forecast To 2030 (US$ Mn) - End User
  • Table 6. US Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 7. US Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 8. US Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 9. US Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 10. Canada Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 11. Canada Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 12. Canada Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 13. Canada Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 14. Mexico Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 15. Mexico Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 16. Mexico Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 17. Mexico Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 18. Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 19. Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 20. Europe Bioanalytical Testing Services Market Revenue And Forecast To 2030 (US$ Mn) - Disease Indication
  • Table 21. Europe Bioanalytical Testing Services Market Revenue And Forecast To 2030 (US$ Mn) - End User
  • Table 22. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 23. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 24. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 25. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 26. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 27. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 28. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 29. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 30. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 31. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 32. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 33. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 34. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 35. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 36. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 37. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 38. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 39. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 40. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 41. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 42. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 43. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 44. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 45. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 46. Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 47. Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 48. Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast To 2030 (US$ Mn) - Disease Indication
  • Table 49. Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast To 2030 (US$ Mn) - End User
  • Table 50. China Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 51. China Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 52. China Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 53. China Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 54. Japan Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 55. Japan Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 56. Japan Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 57. Japan Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 58. India Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 59. India Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 60. India Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 61. India Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 62. Australia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 63. Australia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 64. Australia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 65. Australia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 66. South Korea Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 67. South Korea Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 68. South Korea Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 69. South Korea Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 70. Rest of Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 71. Rest of Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 72. Rest of Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 73. Rest of Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 74. Middle East & Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 75. Middle East & Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 76. Middle East & Africa Bioanalytical Testing Services Market Revenue And Forecast To 2030 (US$ Mn) - Disease Indication
  • Table 77. Middle East & Africa Bioanalytical Testing Services Market Revenue And Forecast To 2030 (US$ Mn) - End User
  • Table 78. UAE Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 79. UAE Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 80. UAE Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 81. UAE Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 82. Saudi Arabia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 83. Saudi Arabia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 84. Saudi Arabia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 85. Saudi Arabia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 86. South Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 87. South Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 88. South Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 89. South Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 90. Rest of Middle East & Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 91. Rest of Middle East & Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 92. Rest of Middle East & Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 93. Rest of Middle East & Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 94. South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 95. South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 96. South & Central America Bioanalytical Testing Services Market Revenue And Forecast To 2030 (US$ Mn) - Disease Indication
  • Table 97. South & Central America Bioanalytical Testing Services Market Revenue And Forecast To 2030 (US$ Mn) - End User
  • Table 98. Brazil Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 99. Brazil Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 100. Brazil Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 101. Brazil Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 102. Argentina Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 103. Argentina Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 104. Argentina Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 105. Argentina Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 106. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 107. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 108. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 109. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 110. Recent Inorganic Growth Strategies in the Bioanalytical Testing Services Market
  • Table 111. Recent Organic Growth Strategies in the Bioanalytical Testing Services Market
  • Table 112. Glossary of Terms, Bioanalytical Testing Services Market

List Of Figures

  • Figure 1. Bioanalytical Testing Services Market Segmentation, By Geography
  • Figure 2. North America - PEST Analysis
  • Figure 3. Europe - PEST Analysis
  • Figure 4. Asia Pacific - PEST Analysis
  • Figure 5. South & Central America - PEST Analysis
  • Figure 6. Middle East & Africa - PEST Analysis
  • Figure 7. Bioanalytical Testing Services Market - Key Industry Dynamics
  • Figure 8. Impact Analysis of Drivers and Restraints
  • Figure 9. Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030
  • Figure 10. Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
  • Figure 11. Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
  • Figure 20. Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Autoimmune Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Respiratory Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 30. Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Contract Development And Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. Bioanalytical Testing Services Market, 2022 ($Mn)
  • Figure 35. North America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 36. North America Bioanalytical Testing Services Market, By Key Countries, 2022 And 2030 (%)
  • Figure 37. US Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 38. Canada Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 39. Mexico Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 40. Europe Bioanalytical Testing Services Market, By Geography, 2022 ($Mn)
  • Figure 41. Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 42. Europe Bioanalytical Testing Services Market, By Key Countries, 2022 And 2030 (%)
  • Figure 43. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 44. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 45. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 46. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 47. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 48. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 49. Bioanalytical Testing Services Market, By Geography, 2022 ($ Million)
  • Figure 50. Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 51. Asia Pacific Bioanalytical Testing Services Market, By Key Countries, 2022 And 2030 (%)
  • Figure 52. China Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 53. Japan Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 54. India Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 55. Australia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 56. South Korea Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 57. Rest of Asia Pacific Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 58. Bioanalytical Testing Services Market, By Geography, 2022 And 2030 ($ Million)
  • Figure 59. Middle East & Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 60. Middle East & Africa Bioanalytical Testing Services Market, By Key Countries, 2022 And 2030 (%)
  • Figure 61. UAE Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 62. Saudi Arabia Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 63. South Africa Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 64. Rest of Middle East & Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 65. Bioanalytical Testing Services Market, By Geography, 2022 ($Mn)
  • Figure 66. South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 67. South & Central America Bioanalytical Testing Services Market, By Key Countries, 2022 And 2030 (%)
  • Figure 68. Brazil Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 69. Argentina Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 70. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 71. Pre & Post Covid-19 Impact
  • Figure 72. Growth Strategies in the Bioanalytical Testing Services Market
目次
Product Code: TIPRE00007336

The global bioanalytical testing services market is expected to reach US$ 10,108.82 million in 2030 from US$ 4,641.13 million in 2022. The market is estimated to grow with a CAGR of 10.2% from 2022 to 2030.

The key factors driving the market's growth are increasing outsourcing of R&D activities by pharmaceutical companies and the high demand for analytical testing of biosimilars and biologics. However, challenges in developing and validating bioanalytical methods are hampering the market's growth to a certain extent.

Market Opportunities of Bioanalytical Testing Services Market

The research & development, production, and distribution of medicinal drugs and other pharmaceutical products are the major areas of the pharmaceutical industry. Global pharmaceutical consumption is rising with the increasing need for drugs to treat age-related diseases and chronic diseases. According to the WHO, the elderly population aged 60 or above is projected to double from 2020 to 2050, reaching ~2.1 billion by 2050. A rise in the geriatric population would contribute to a surge in incidences of chronic diseases, such as cardiovascular diseases, cancer, hypertension, osteoarthritis, and diabetes mellitus. Thus, chronic diseases have been a major area of focus for pharmaceutical companies.

New drug development is a resource-, cost-, and time-intensive process, where later clinical stages result in significant costs. As per the United States Congressional Budget Office (CBO), it takes over 10-15 years and costs around US$ 1-2 billion to discover a drug and obtain regulatory approval. Therefore, to lower the attrition rate in drug research & development, pharmaceutical companies are focusing on following the good manufacturing practices (GMP) set by the US FDA and other major regulatory organizations. Several pharmaceutical companies are opting for bioanalytical testing services for drug development and validation of assays in both clinical and preclinical stages. Generics and branded drug compounds are mostly small molecules. Generics manufacturers conduct and submit bioanalytical testing results to overcome the issue of patent expiration. Thus, with the uninterrupted proliferation of the pharmaceutical industry, bioanalytical testing service providers are likely to experience a continuous rise in demand for their services in the future, which would lead to new growth opportunities in the bioanalytical testing services market.

Factors Hampering Bioanalytical Testing Services Market

Developing bioanalytical methods is a complex process that necessitates a dexterous approach by skilled professionals. As a result, several challenges are associated with the development and validation of biological analysis methods. According to Simbec-Orion, a UK-based clinical research organization for complex clinical studies, FDA reviewers have outlined challenges such as analytical issues, flawed extraction techniques, calculation problems, reporting issues, and sample shipping issues related to bioanalytical testing methods. Various analytical issues may arise during the sample preparation and analysis stage; these include deterioration of analytical columns in HPLC; contamination in the mobile phase; issues arising from the complexity of sample matrices in LCMS; and contamination of other stages of LCMS. These hamper the bioanalytical test validation and simultaneously affect the quality standards, thereby limiting the growth of the bioanalytical testing services market.

Bioanalytical Testing Services Market: Segmental Overview

Based on services, the bioanalytical testing services market is segmented into pharmacokinetics, biomarkers, immunogenicity, virology testing, cell-based assays, and others. The cell-based assays segment held the largest market share in 2022. Furthermore, the same segment is anticipated to register the highest CAGR from 2022 to 2030. Cell-based assays are commonly used to determine the biological activity (potency) of the drug product or drug substance and discover the mechanism of action (MOA), as well as for cytotoxicity testing and early-stage proof-of-principal studies. While in immunogenicity studies, it helps in determining drug neutralization effect of antibodies produced in the patient's body.

Based on disease indication, the bioanalytical testing services market is segmented into cardiovascular, neurological disorders (CNS), metabolic disorders, oncology, sexual health, bone disease, and others. In 2022, the oncology segment held the market's largest share. Also, the same segment is expected to grow in demand at the fastest CAGR from 2022 to 2030, owing to the advances in oncology for pain relief, chemotherapy, and other therapies.

Based on end users, the bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations (CRO), contract development and manufacturing organization (CDMO), and others. In 2022, the pharmaceutical and biopharmaceutical companies segment held the largest market share. Furthermore, the same segment is expected to witness growth in demand at the fastest CAGR from 2022 to 2030. The bioanalytical test services aim to eliminate the risks involved from the beginning of the pharmaceutical production to the final product release. Thus, the cruciality of bioanalytical testing services in drug discovery and development drives the bioanalytical testing services market for the pharmaceutical and biopharmaceutical companies segment.

Bioanalytical Testing Services Market: Geographical Overview

North America holds the largest share of the global bioanalytical testing services market, whereas the Asia Pacific is the fastest-growing region. The market in North America is expected to grow during the forecast period owing to the uninterrupted growth of the pharmaceuticals industry, the increasing need for developing novel drugs due to an upsurge in the incidences of various diseases, rising healthcare expenditure by governments, and a growing preference for outsourcing activities for the quality assurance of pharmaceutical products. Asia Pacific registered the highest CAGR in the global bioanalytical testing services testing market. The market in the region is expected to grow significantly in countries, including China, India, and Japan, in the coming years. The Asia Pacific market is expected to grow due to the increasing demand for outsourcing services in the low-cost labor markets. Therefore, the region holds huge potential for the bioanalytical testing services market players to grow during the forecast period.

A few of the major primary and secondary sources referred to while preparing the report on the bioanalytical testing services market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and EPA (Environmental Protection Agency).

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in thebioanalytical testing services market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the globalbioanalytical testing services market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving thebioanalytical testing services market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Bioanalytical Testing Services Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 South & Central America PEST Analysis
    • 4.2.5 Middle East & Africa PEST Analysis

5. Bioanalytical Testing Services Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Outsourcing of R&D Activities by Pharmaceutical Companies
    • 5.1.2 High Demand for Analytical Testing of Biosimilars and Biologics
  • 5.2 Key Market Restraints:
    • 5.2.1 Challenges in Development and Validation of Bioanalytical Methods
  • 5.3 Key Market Opportunities
    • 5.3.1 Uninterrupted Growth of Pharmaceuticals Industry
  • 5.4 Future Trends
    • 5.4.1 Rising Drug Discovery and Development Activities for Emerging and Rare Diseases
  • 5.5 Impact Analysis:

6. Bioanalytical Testing Services Market - Global Market Analysis

  • 6.1 Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030

7. Global Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Services

  • 7.1 Overview
  • 7.2 Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
  • 7.3 Pharmacokinetics
    • 7.3.1 Overview
    • 7.3.2 Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Biomarkers
    • 7.4.1 Overview
    • 7.4.2 Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Immunogenicity
    • 7.5.1 Overview
    • 7.5.2 Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Virology Testing
    • 7.6.1 Overview
    • 7.6.2 Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.6.2.1 In-Vitro Virology Testing
        • 7.6.2.1.1 Overview
        • 7.6.2.1.2 In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.6.2.2 In-Vivo Virology Testing
        • 7.6.2.2.1 Overview
        • 7.6.2.2.2 In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Cell-Based Assays
    • 7.7.1 Overview
    • 7.7.2 Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Disease Indication

  • 8.1 Overview
  • 8.2 Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
  • 8.3 Cardiovascular
    • 8.3.1 Overview
    • 8.3.2 Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Neurological Diseases
    • 8.4.1 Overview
    • 8.4.2 Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Autoimmune Disorders
    • 8.5.1 Overview
    • 8.5.2 Autoimmune Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Respiratory Diseases
    • 8.6.1 Overview
    • 8.6.2 Respiratory Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Metabolic Disorders
    • 8.7.1 Overview
    • 8.7.2 Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Oncology
    • 8.8.1 Overview
    • 8.8.2 Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Sexual Health
    • 8.9.1 Overview
    • 8.9.2 Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Bone Disease
    • 8.10.1 Overview
    • 8.10.2 Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.11 Others
    • 8.11.1 Overview
    • 8.11.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Pharmaceutical and Biopharmaceutical Companies
    • 9.3.1 Overview
    • 9.3.2 Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Contract Research Organization (CRO)
    • 9.4.1 Overview
    • 9.4.2 Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Contract Development And Manufacturing Organization (CDMO)
    • 9.5.1 Overview
    • 9.5.2 Contract Development And Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

10. Bioanalytical Testing Services Market - Geographical Analysis

  • 10.1 North America Bioanalytical Testing Services Market, Revenue And Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 North America Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.1.2.1 North America Bioanalytical Testing Services Market, by Services
        • 10.1.2.1.1 North America Bioanalytical Testing Services Market, by Virology Testing
      • 10.1.2.2 North America Bioanalytical Testing Services Market, by Disease Indication
      • 10.1.2.3 North America Bioanalytical Testing Services Market, by End User
      • 10.1.2.4 North America Bioanalytical Testing Services Market, by Country
      • 10.1.2.5 US
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 US Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.5.3 US Bioanalytical Testing Services Market, by Services
        • 10.1.2.5.3.1 US Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.2.5.4 US Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.2.5.5 US Bioanalytical Testing Services Market, by End User
      • 10.1.2.6 Canada
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Canada Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.3 Canada Bioanalytical Testing Services Market, by Services
        • 10.1.2.6.3.1 Canada Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.2.6.4 Canada Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.2.6.5 Canada Bioanalytical Testing Services Market, by End User
      • 10.1.2.7 Mexico
        • 10.1.2.7.1 Overview
        • 10.1.2.7.2 Mexico Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.7.3 Mexico Bioanalytical Testing Services Market, by Services
        • 10.1.2.7.3.1 Mexico Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.2.7.4 Mexico Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.2.7.5 Mexico Bioanalytical Testing Services Market, by End User
  • 10.2 Europe Bioanalytical Testing Services Market, Revenue And Forecast to 2030
    • 10.2.1 Overview
    • 10.2.2 Europe Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.2.2.1 Europe Bioanalytical Testing Services Market, by Services
        • 10.2.2.1.1 Europe Bioanalytical Testing Services Market, by Virology Testing
      • 10.2.2.2 Europe Bioanalytical Testing Services Market, by Disease Indication
      • 10.2.2.3 Europe Bioanalytical Testing Services Market, by End User
      • 10.2.2.4 Europe Bioanalytical Testing Services Market by Country
      • 10.2.2.5 Germany
        • 10.2.2.5.1 Overview
        • 10.2.2.5.2 Germany Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.5.3 Germany Bioanalytical Testing Services Market, by Services
        • 10.2.2.5.3.1 Germany Bioanalytical Testing Services Market, by Virology Testing
        • 10.2.2.5.4 Germany Bioanalytical Testing Services Market, by Disease Indication
        • 10.2.2.5.5 Germany Bioanalytical Testing Services Market, by End User
      • 10.2.2.6 UK
        • 10.2.2.6.1 Overview
        • 10.2.2.6.2 UK Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.6.3 UK Bioanalytical Testing Services Market, by Services
        • 10.2.2.6.3.1 UK Bioanalytical Testing Services Market, by Virology Testing
        • 10.2.2.6.4 UK Bioanalytical Testing Services Market, by Disease Indication
        • 10.2.2.6.5 UK Bioanalytical Testing Services Market, by End User
      • 10.2.2.7 France
        • 10.2.2.7.1 Overview
        • 10.2.2.7.2 France Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.7.3 France Bioanalytical Testing Services Market, by Services
        • 10.2.2.7.3.1 France Bioanalytical Testing Services Market, by Virology Testing
        • 10.2.2.7.4 France Bioanalytical Testing Services Market, by Disease Indication
        • 10.2.2.7.5 France Bioanalytical Testing Services Market, by End User
      • 10.2.2.8 Italy
        • 10.2.2.8.1 Overview
        • 10.2.2.8.2 Italy Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.8.3 Italy Bioanalytical Testing Services Market, by Services
        • 10.2.2.8.3.1 Italy Bioanalytical Testing Services Market, by Virology Testing
        • 10.2.2.8.4 Italy Bioanalytical Testing Services Market, by Disease Indication
        • 10.2.2.8.5 Italy Bioanalytical Testing Services Market, by End User
      • 10.2.2.9 Spain
        • 10.2.2.9.1 Overview
        • 10.2.2.9.2 Spain Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.9.3 Spain Bioanalytical Testing Services Market, by Services
        • 10.2.2.9.3.1 Spain Bioanalytical Testing Services Market, by Virology Testing
        • 10.2.2.9.4 Spain Bioanalytical Testing Services Market, by Disease Indication
        • 10.2.2.9.5 Spain Bioanalytical Testing Services Market, by End User
      • 10.2.2.10 Rest of Europe
        • 10.2.2.10.1 Overview
        • 10.2.2.10.2 Rest of Europe Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.10.3 Rest of Europe Bioanalytical Testing Services Market, by Services
        • 10.2.2.10.3.1 Rest of Europe Bioanalytical Testing Services Market, by Virology Testing
        • 10.2.2.10.4 Rest of Europe Bioanalytical Testing Services Market, by Disease Indication
        • 10.2.2.10.5 Rest of Europe Bioanalytical Testing Services Market, by End User
  • 10.3 Asia Pacific Bioanalytical Testing Services Market, Revenue And Forecast to 2030
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.3.2.1 Asia Pacific Bioanalytical Testing Services Market, by Services
        • 10.3.2.1.1 Asia Pacific Bioanalytical Testing Services Market, by Virology Testing
      • 10.3.2.2 Asia Pacific Bioanalytical Testing Services Market, by Disease Indication
      • 10.3.2.3 Asia Pacific Bioanalytical Testing Services Market, by End User
      • 10.3.2.4 Asia Pacific Bioanalytical Testing Services Market by Country
      • 10.3.2.5 China
        • 10.3.2.5.1 Overview
        • 10.3.2.5.2 China Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.5.3 China Bioanalytical Testing Services Market, by Services
        • 10.3.2.5.3.1 China Bioanalytical Testing Services Market, by Virology Testing
        • 10.3.2.5.4 China Bioanalytical Testing Services Market, by Disease Indication
        • 10.3.2.5.5 China Bioanalytical Testing Services Market, by End User
      • 10.3.2.6 Japan
        • 10.3.2.6.1 Overview
        • 10.3.2.6.2 Japan Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.6.3 Japan Bioanalytical Testing Services Market, by Services
        • 10.3.2.6.3.1 Japan Bioanalytical Testing Services Market, by Virology Testing
        • 10.3.2.6.4 Japan Bioanalytical Testing Services Market, by Disease Indication
        • 10.3.2.6.5 Japan Bioanalytical Testing Services Market, by End User
      • 10.3.2.7 India
        • 10.3.2.7.1 Overview
        • 10.3.2.7.2 India Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.7.3 India Bioanalytical Testing Services Market, by Services
        • 10.3.2.7.3.1 India Bioanalytical Testing Services Market, by Virology Testing
        • 10.3.2.7.4 India Bioanalytical Testing Services Market, by Disease Indication
        • 10.3.2.7.5 India Bioanalytical Testing Services Market, by End User
      • 10.3.2.8 Australia
        • 10.3.2.8.1 Overview
        • 10.3.2.8.2 Australia Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.8.3 Australia Bioanalytical Testing Services Market, by Services
        • 10.3.2.8.3.1 Australia Bioanalytical Testing Services Market, by Virology Testing
        • 10.3.2.8.4 Australia Bioanalytical Testing Services Market, by Disease Indication
        • 10.3.2.8.5 Australia Bioanalytical Testing Services Market, by End User
      • 10.3.2.9 South Korea
        • 10.3.2.9.1 Overview
        • 10.3.2.9.2 South Korea Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.9.3 South Korea Bioanalytical Testing Services Market, by Services
        • 10.3.2.9.3.1 South Korea Bioanalytical Testing Services Market, by Virology Testing
        • 10.3.2.9.4 South Korea Bioanalytical Testing Services Market, by Disease Indication
        • 10.3.2.9.5 South Korea Bioanalytical Testing Services Market, by End User
      • 10.3.2.10 Rest of Asia Pacific
        • 10.3.2.10.1 Overview
        • 10.3.2.10.2 Rest of Asia Pacific Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.10.3 Rest of Asia Pacific Bioanalytical Testing Services Market, by Services
        • 10.3.2.10.3.1 Rest of Asia Pacific Bioanalytical Testing Services Market, by Virology Testing
        • 10.3.2.10.4 Rest of Asia Pacific Bioanalytical Testing Services Market, by Disease Indication
        • 10.3.2.10.5 Rest of Asia Pacific Bioanalytical Testing Services Market, by End User
  • 10.4 Middle East & Africa Bioanalytical Testing Services Market, Revenue And Forecast to 2030
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.4.2.1 Middle East & Africa Bioanalytical Testing Services Market, by Services
        • 10.4.2.1.1 Middle East & Africa Bioanalytical Testing Services Market, by Virology Testing
      • 10.4.2.2 Middle East & Africa Bioanalytical Testing Services Market, by Disease Indication
      • 10.4.2.3 Middle East & Africa Bioanalytical Testing Services Market, by End User
      • 10.4.2.4 Middle East & Africa Bioanalytical Testing Services Market by Country
      • 10.4.2.5 UAE
        • 10.4.2.5.1 Overview
        • 10.4.2.5.2 UAE Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.5.3 UAE Bioanalytical Testing Services Market, by Services
        • 10.4.2.5.3.1 UAE Bioanalytical Testing Services Market, by Virology Testing
        • 10.4.2.5.4 UAE Bioanalytical Testing Services Market, by Disease Indication
        • 10.4.2.5.5 UAE Bioanalytical Testing Services Market, by End User
      • 10.4.2.6 Saudi Arabia
        • 10.4.2.6.1 Overview
        • 10.4.2.6.2 Saudi Arabia Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.6.3 Saudi Arabia Bioanalytical Testing Services Market, by Services
        • 10.4.2.6.3.1 Saudi Arabia Bioanalytical Testing Services Market, by Virology Testing
        • 10.4.2.6.4 Saudi Arabia Bioanalytical Testing Services Market, by Disease Indication
        • 10.4.2.6.5 Saudi Arabia Bioanalytical Testing Services Market, by End User
      • 10.4.2.7 South Africa
        • 10.4.2.7.1 Overview
        • 10.4.2.7.2 South Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.7.3 South Africa Bioanalytical Testing Services Market, by Services
        • 10.4.2.7.3.1 South Africa Bioanalytical Testing Services Market, by Virology Testing
        • 10.4.2.7.4 South Africa Bioanalytical Testing Services Market, by Disease Indication
        • 10.4.2.7.5 South Africa Bioanalytical Testing Services Market, by End User
      • 10.4.2.8 Rest of Middle East & Africa
        • 10.4.2.8.1 Overview
        • 10.4.2.8.2 Rest of Middle East & Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.8.3 Rest of Middle East & Africa Bioanalytical Testing Services Market, by Services
        • 10.4.2.8.3.1 Rest of Middle East & Africa Bioanalytical Testing Services Market, by Virology Testing
        • 10.4.2.8.4 Rest of Middle East & Africa Bioanalytical Testing Services Market, by Disease Indication
        • 10.4.2.8.5 Rest of Middle East & Africa Bioanalytical Testing Services Market, by End User
  • 10.5 South & Central America Bioanalytical Testing Services Market, Revenue And Forecast to 2030
    • 10.5.1 Overview
    • 10.5.2 South & Central America Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.5.2.1 South & Central America Bioanalytical Testing Services Market, by Services
        • 10.5.2.1.1 South & Central America Bioanalytical Testing Services Market, by Virology Testing
      • 10.5.2.2 South & Central America Bioanalytical Testing Services Market, by Disease Indication
      • 10.5.2.3 South & Central America Bioanalytical Testing Services Market, by End User
      • 10.5.2.4 South & Central America Bioanalytical Testing Services Market by Country
      • 10.5.2.5 Brazil
        • 10.5.2.5.1 Overview
        • 10.5.2.5.2 Brazil Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.2.5.3 Brazil Bioanalytical Testing Services Market, by Services
        • 10.5.2.5.3.1 Brazil Bioanalytical Testing Services Market, by Virology Testing
        • 10.5.2.5.4 Brazil Bioanalytical Testing Services Market, by Disease Indication
        • 10.5.2.5.5 Brazil Bioanalytical Testing Services Market, by End User
      • 10.5.2.6 Argentina
        • 10.5.2.6.1 Overview
        • 10.5.2.6.2 Argentina Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.2.6.3 Argentina Bioanalytical Testing Services Market, by Services
        • 10.5.2.6.3.1 Argentina Bioanalytical Testing Services Market, by Virology Testing
        • 10.5.2.6.4 Argentina Bioanalytical Testing Services Market, by Disease Indication
        • 10.5.2.6.5 Argentina Bioanalytical Testing Services Market, by End User
      • 10.5.2.7 Rest of South & Central America
        • 10.5.2.7.1 Overview
        • 10.5.2.7.2 Rest of South & Central America Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.2.7.3 Rest of South & Central America Bioanalytical Testing Services Market, by Services
        • 10.5.2.7.3.1 Rest of South & Central America Bioanalytical Testing Services Market, by Virology Testing
        • 10.5.2.7.4 Rest of South & Central America Bioanalytical Testing Services Market, by Disease Indication
        • 10.5.2.7.5 Rest of South & Central America Bioanalytical Testing Services Market, by End User

11. Pre & Post Covid-19 Impact

  • 11.1 Pre & Post Covid-19 Impact

12. Bioanalytical Testing Services Market Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Bioanalytical Testing Services Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 SGS SA
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Pharmaron Beijing Co Ltd
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Element Materials Technology Group Ltd
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 CD BioSciences Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Charles River Laboratories International Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Eurofins Scientific SE
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Labcorp Drug Development Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Syneos Health Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 KCAS Bioanalytical and Biomarker Services LLC
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 ICON Plc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Intertek Group Plc
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms